Brief: Diagonal Bio Q3 Operating Loss Narrows To SEK 3.8 Million
16/11/2022 07:12
Nov 16 (Reuters) - Diagonal Bio AB 9F1.F :
* Q3 REVENUE SEK 1.3 MILLION VERSUS SEK 2.2 MILLION YEAR AGO
* Q3 OPERATING LOSS SEK 3.8 MILLION VERSUS LOSS SEK 4.3
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr2M4K3p
Further company coverage: 9F1.F
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))